InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,685.98
(
-0.41%
)
US TECH 100
19,254.40
(
-0.12%
)
Dow Jones
41,903.28
(
-0.69%
)
Brent Oil
76.69
(
2.77%
)
Bitcoin
60,074.49
(
-0.91%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

walldiver

Send PM Follow Ignore
Followers 24
Posts 1614
Boards Moderated 0
Alias Born 01/02/2003

walldiver

Re: DewDiligence post# 3481

Friday, 05/11/2007 9:01:03 PM

Friday, May 11, 2007 9:01:03 PM

Post# of 12660
Dew, I'm assuming that when Aschoff says DNDN will need to do an additional trial other than 9902B, he means that 9902B will fail. He always says that 9902B will fail, because he believes Provenge has no clinical benefit.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up